WallStreetZenWallStreetZen

NASDAQ: CSCI
Cosciens Biopharma Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Cosciens Biopharma earnings were -$18.6M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest CSCI earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$5.8M, up 304.7% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CSCI reported annual earnings of -$16.6M, with -27.2% growth.

CSCI earnings history

Current Revenue
$4.3M
Current Earnings
-$18.6M
Current Profit Margin
-428.4%

CSCI Return on Equity

Current Company
-92.5%
Current Industry
19.9%
Current Market
35%
CSCI's Return on Equity (-95.9%)... subscribe to Premium to read more.
High Return on Equity Performance

CSCI undefined

Current Company
-49.7%
Current Industry
1.3%
CSCI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CSCI announces earnings.

CSCI undefined

Current Company
-53.67%
Current Industry
14.3%
CSCI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CSCI vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CSCI-$18.16M-$18.56MN/A-$11.87
RLMD-$86.49M-$86.49MN/A-$2.86
NEUPN/A-$1.81MN/A-$2.56
ACXP-$14.10M-$14.10MN/A-$0.87
EVGN-$10.63M-$16.49MN/A-$2.89
View Top Biotech Stocks

Cosciens Biopharma Earnings Reports & History FAQ

What were Cosciens Biopharma's earnings last quarter?

On CSCI's earnings call on Invalid Date, Cosciens Biopharma (NASDAQ: CSCI) reported Q3 2024 earnings per share (EPS) of -$1.85, up 340.48% year over year. Total CSCI earnings for the quarter were -$5.76 million. In the same quarter last year, Cosciens Biopharma's earnings per share (EPS) was -$0.42.

If you're new to stock investing, here's how to buy Cosciens Biopharma stock.

Is Cosciens Biopharma profitable or losing money?

As of the last Cosciens Biopharma earnings report, Cosciens Biopharma is currently losing money. Cosciens Biopharma's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$18.56 million, a 1.21% increase year over year.

What was CSCI's earnings growth in the past year?

As of Cosciens Biopharma's earnings date in Invalid Date, Cosciens Biopharma's earnings has grown year over year. CSCI earnings in the past year totalled -$18.56 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.